The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia

被引:39
|
作者
Li, Qiongzhen [1 ,2 ]
Du, Xiangdong [1 ]
Zhang, Yingyang [1 ]
Yin, Guangzhong [1 ]
Zhang, Guangya [1 ]
Walss-Bass, Consuelo [2 ]
Quevedo, Joao [2 ]
Soares, Jair C. [2 ]
Xia, Haishen [3 ]
Li, Xiaosi [3 ]
Zheng, Yingjun [4 ]
Ning, Yuping [4 ]
Zhang, Xiang Yang [2 ,5 ]
机构
[1] Soochow Univ, Affiliated Guangji Hosp, Suzhou Psychiat Hosp, Suzhou, Jiangsu, Peoples R China
[2] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA
[3] Anhui Mental Hlth Ctr, Hefei Peoples Hosp 4, Hefei, Peoples R China
[4] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China
[5] Beijing HuiLongGuan Hosp, Psychiat Res Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Schizophrenia; Chinese; Obesity; BMI; PANSS; ACUTE WEIGHT-GAIN; METABOLIC SYNDROME; ATYPICAL ANTIPSYCHOTICS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; BODY-MASS; CLOZAPINE; PSYCHOPATHOLOGY; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1016/j.psychres.2016.12.041
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Obesity is a common comorbidity in schizophrenia. Few studies have addressed obesity in Chinese schizophrenia patients. The aims of this current study were to evaluate the prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia. A total of 206 patients were recruited from a hospital in Beijing. Their clinical and anthropometric data together with plasma glucose and lipid parameters were collected. Positive and Negative Syndrome Scale (PANSS) was rated for all patients. Overall, 43 (20.9%) patients were obese and 67 (32.5%) were overweight. The obese patients had significantly higher glucose levels, triglyceride levels than non-obese patients. Females and patients with type 2 diabetes mellitus had increased risk for obesity. Correlation analysis showed that BMI was associated with sex, education levels, negative symptoms, total PANSS score, triglyceride levels and type 2 diabetes mellitus. Further stepwise regression analysis showed that sex, type 2 diabetes, education level, triglyceride and amount of smoking/day were significant predictors for obesity. Our study showed that the prevalence of obesity in Chinese patients with schizophrenia is higher than that in the general population. Some demographic and clinical variables are risk factors for obesity in schizophrenia.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 50 条
  • [1] The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia
    Huo, Lijuan
    Zhang, Guangya
    Du, Xiang-Dong
    Jia, Qiaqiufang
    Qian, Zheng-Kang
    Chen, Dachun
    Xiu, Meihong
    Wu, Fengchun
    Soares, Jair C.
    Huang, Xingbing
    Cassidy, Ryan M.
    Ning, Yuping
    Zhang, Xiang Yang
    [J]. SCHIZOPHRENIA RESEARCH, 2020, 218 : 262 - 266
  • [2] Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia
    Uludag, Kadir
    Wang, Dong Mei
    Goodman, Colin
    Chen, Da Chun
    Wang, Li
    Zhang, Xiangyang
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2021, 66
  • [3] The Prevalence, Risk Factors and Clinical Correlates of QTc Prolongation in Chinese Hospitalized Patients With Chronic Schizophrenia
    Cao, Haiyan
    Zhou, Yongjie
    Li, Tao
    Yao, Cong
    Yang, Weiliang
    Kong, Siying
    Wang, Yanyan
    Yu, Baoping
    Jiao, Qingyan
    Sun, Yun
    Jia, Xiaoju
    Wang, Yuting
    Wang, Zhonggang
    Zhang, Xiangyang
    Li, Jie
    [J]. FRONTIERS IN PSYCHIATRY, 2021, 12
  • [4] Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits
    Tian, Yang
    Liu, Dianying
    Wang, Dongmei
    Wang, Jiesi
    Xu, Hang
    Dai, Qilong
    Andriescue, Elena C.
    Wu, Hanjing E.
    Xiu, Meihong
    Chen, Dachun
    Wang, Li
    Chen, Yiwen
    Yang, Ruilang
    Wu, Anshi
    Wei, Chang Wei
    Zhang, Xiangyang
    [J]. SCHIZOPHRENIA RESEARCH, 2020, 215 : 270 - 276
  • [5] The prevalence, risk factors, and clinical characteristics of insulin resistance in Chinese patients with schizophrenia
    Lin, Chen
    Chen, Ke
    Zhang, Rongzhen
    Fu, Weihong
    Yu, Jianjin
    Gao, Lan
    Ni, Haiqing
    Song, Jiaqi
    Chen, Dachun
    [J]. COMPREHENSIVE PSYCHIATRY, 2020, 96
  • [6] Prevalence, Sociodemographic, and Clinical Correlates of Older Chinese Patients With Deficit Schizophrenia
    Liu, Junjun
    He, Jinfeng
    Cheng, Min
    Cao, Hui
    Zhang, Xiangrong
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2019, 32 (06) : 298 - 303
  • [7] Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia
    Xiang Yang Zhang
    Da Chun Chen
    Ling Yan Qi
    Fang Wang
    Mei Hong Xiu
    Song Chen
    Gui Ying Wu
    Therese A. Kosten
    Thomas R. Kosten
    [J]. Psychopharmacology, 2009, 205 : 647 - 654
  • [8] Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia
    Zhang, Xiang Yang
    Chen, Da Chun
    Qi, Ling Yan
    Wang, Fang
    Xiu, Mei Hong
    Chen, Song
    Wu, Gui Ying
    Kosten, Therese A.
    Kosten, Thomas R.
    [J]. PSYCHOPHARMACOLOGY, 2009, 205 (04) : 647 - 654
  • [9] Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia
    Cui, Jingyi
    Liu, Huaqing
    Shao, Jing
    Xu, Dong-Mei
    Wang, Yi
    Fei, Zheng
    Wei, Jiyu
    Lu, Wei
    Wang, Chun-Rong
    He, Rui
    Tan, Yangya
    Fan, Yi
    Ning, Yuping
    Cassidy, Ryan M.
    Soares, Jair C.
    Huang, Xingbing
    Zhang, Xiang Yang
    [J]. SCHIZOPHRENIA RESEARCH, 2018, 195 : 488 - 494
  • [10] Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia
    Zhu, Rongrong
    Wang, Dongmei
    Zhou, Huixia
    Wang, Wenjia
    Wei, Shuochi
    Chen, Dachun
    Xiu, Meihong
    Wang, Li
    Zhang, Xiang-Yang
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2023, 273 (03) : 601 - 611